An urban slum study site in Salvador, Brazil where Dr. Ko and his team are conducting long-term cohort studies to study the natural history of leptospirosis and identify community-based interventions.Albert Ko, M.D., of the Division of Infectious Diseases, received a 3-year, $2.8 million phase II Small Business Innovative Research Grant (SBIR) from the NIH to fully develop a rapid diagnostic test for leptospirosis. Dr. Ko received this grant in collaboration with Chembio Diagnostic Systems, Inc...
Read More